Space For Rent
Friday, June 17, 2016, Ashar 3, 1423 BS, Ramadan 11, 1437 Hijri


Beximco Pharma starts medicine export to Kuwait
Business Correspondent
Published :Friday, 17 June, 2016,  Time : 12:00 AM  View Count : 48
Beximco Pharmaceuticals Limited (BPL), a leading medicine manufacturers and exporters in the country, has started exporting pharmacy products to Kuwait.
This is the first time a Bangladeshi pharmaceutical company has dispatched pharmaceutical products to a member country of Gulp Cooperative Council (GCC).
The shipment of the first consignment to Kuwait was inaugurated at a ceremony held at the factory premises of Beximco Pharma at Tongi on Thursday.
Ambassador of Kuwait to Bangladesh Adel Mohammad A. H Hayat, Beximco Group Vice Chairman Salman F Rahman, Beximco Pharma's Managing Director Nazmul Hassan, MP, Chief operating Officer Rabbur Reza and other high officials of the BPL were also present at the ceremony.
The ambassador has also witnessed the operations of various units at Tongi factory and expressed high satisfaction over the state-of-the-art facilities and quality control practices of Beximco Pharma. He expressed keen interest in Beximco medicines and hoped for substantial import from the company in the near future.
Initially two metered dose inhaler products for asthma and respiratory disorders namely Azmasol (Salbutamol) and Bexitrol-F (Salmeterol plus Fluticasone) and one blood pressure drug Amdocal (Amlodipine) are being exported to Kuwait.
The Company expects to launch additional products in Kuwait later this year. Total pharma market of the Gulf Cooperation Council (GCC), consisting of six Arab nations, is currently valued at around $9 billion and Kuwait has a pharma market worth about a billion dollar.
Answering to the questions from journalists at the ceremony Salman F Rahman said: "Beximco pharma is exporting medicine to 54 countries including Kuwait. Beximco Pharma had worked hard for the last seven years to get necessary approvals from the authority which are normally a lengthy process as well. Now we are expecting to export 1 billion dollar within next five years which was 15 million dollar las year."
On this occasion, the Managing Director of Beximco Pharma, Nazmul Hassan MP, also the President of Bangladesh Cricket Board said: "Beximco Pharma is building its presence in many emerging and developed markets. The Company is increasingly focused on regulated markets such as the US, EU, GCC and Australia where the demand for generic products is rising."
Gulf or GCC is an important market for us and the launch of products in Kuwait will open up new business opportunities for the company. Beximco will continue to expand our product basket for the gulf region aiming to provide patients with safe and affordable treatment options, he said.










Editor : Iqbal Sobhan Chowdhury
Published by the Editor on behalf of the Observer Ltd. from Globe Printers, 24/A, New Eskaton Road, Ramna, Dhaka. Editorial, News and Commercial Offices : Aziz Bhaban (2nd floor), 93, Motijheel C/A, Dhaka-1000. Phone :9586651-58. Fax: 9586659-60, Advertisemnet: 9513663, E-mail: [email protected], [email protected], [email protected].